pazopanib and Adenoma--Oxyphilic

pazopanib has been researched along with Adenoma--Oxyphilic* in 2 studies

Other Studies

2 other study(ies) available for pazopanib and Adenoma--Oxyphilic

Article	Year
Pazopanib in the Treatment of Bilateral Multifocal Renal Oncocytomas: A Case Report. Clinical genitourinary cancer, 2018, Volume: 16, Issue:3 Topics: Adenoma, Oxyphilic; Administration, Oral; Combined Modality Therapy; Humans; Indazoles; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Treatment Outcome	2018
Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-01, Volume: 28, Issue:19 Topics: Adenoma, Oxyphilic; Adult; Black or African American; Female; Hair; Humans; Hypopigmentation; Indazoles; Protein Kinase Inhibitors; Pyrimidines; Skin; Sulfonamides; Thyroid Neoplasms	2010

Article

Year

Pazopanib in the Treatment of Bilateral Multifocal Renal Oncocytomas: A Case Report.

Clinical genitourinary cancer, 2018, Volume: 16, Issue:3

Topics: Adenoma, Oxyphilic; Administration, Oral; Combined Modality Therapy; Humans; Indazoles; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Treatment Outcome

2018

Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-01, Volume: 28, Issue:19

Topics: Adenoma, Oxyphilic; Adult; Black or African American; Female; Hair; Humans; Hypopigmentation; Indazoles; Protein Kinase Inhibitors; Pyrimidines; Skin; Sulfonamides; Thyroid Neoplasms

2010